| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RUBY | Rubius Therapeutics, Inc. | CAGNONI PABLO J | Director | Feb 01, 2023 | Sale | $0.25 | 8,448 | 2,112 | 66,082 | Feb 01, 2023, 09:41 PM | |
| RUBY | Rubius Therapeutics, Inc. | CAGNONI PABLO J | Director | Jan 31, 2023 | Sale | $0.24 | 7,240 | 1,745 | 74,530 | Jan 31, 2023, 09:51 PM | |
| RUBY | Rubius Therapeutics, Inc. | CAGNONI PABLO J | CEO and President | Feb 01, 2022 | Sale | $6.57 | 6,730 | 44,236 | 35,520 | Feb 01, 2022, 09:20 PM | |
| RUBY | Rubius Therapeutics, Inc. | CAGNONI PABLO J | CEO and President | Apr 14, 2020 | Buy | $4.70 | 21,000 | 98,694 | 21,000 | Apr 15, 2020, 05:14 PM | |
| CRSP | CRISPR Therapeutics AG | CAGNONI PABLO J | Director | Nov 19, 2019 | Option Exercise | $33.80 | 15,000 | 506,925 | 7,500 | Nov 21, 2019, 04:07 PM | |
| CRSP | CRISPR Therapeutics AG | CAGNONI PABLO J | Director | Nov 12, 2019 | Option Exercise | $30.30 | 15,000 | 454,425 | 7,500 | Nov 13, 2019, 04:30 PM | |
| CRSP | CRISPR Therapeutics AG | CAGNONI PABLO J | Director | Oct 30, 2019 | Option Exercise | $28.80 | 15,000 | 431,925 | 7,500 | Nov 01, 2019, 06:35 PM | |
| CRSP | CRISPR Therapeutics AG | CAGNONI PABLO J | Director | Jul 03, 2018 | Option Exercise | $33.80 | 11,632 | 393,103 | 5,816 | Jul 05, 2018, 06:25 PM | |
| CRSP | CRISPR Therapeutics AG | CAGNONI PABLO J | Director | Jul 05, 2018 | Option Exercise | $33.80 | 3,368 | 113,822 | 1,684 | Jul 05, 2018, 06:25 PM | |
| ONXX | ONYX PHARMACEUTICALS INC | CAGNONI PABLO J | EVP, Global R&D and Tech Ops | Oct 01, 2013 | Option Exercise | $125.00 | 16,257 | 2,032,125 | 0 | Oct 03, 2013, 09:39 PM |
Menu